{
    "nctId": "NCT00504699",
    "briefTitle": "Safety of Ovarian Stimulation With Letrozole and Gonadotropins in Breast Cancer Patients",
    "officialTitle": "Safety of Ovarian Stimulation With Letrozole and Gonadotropins in Breast Cancer Patients Undergoing Embryo or Oocyte Cryopreservation: A Prospective Controlled Follow up Study",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "OTHER",
    "enrollmentCount": 120,
    "primaryOutcomeMeasure": "Breast cancer relapse free survival after ovarian stimulation",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age 18-45 years\n* Biopsy proven breast cancer\n* No prior chemotherapy or oophorectomy\n* Regular menstrual cycles\n* Normal basal FSH and estradiol\n\nExclusion Criteria:\n\n* Stage 4 breast cancer",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}